Cargando…
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface
Lysyl oxidase (LOX) remodels the tumour microenvironment by cross-linking the extracellular matrix. LOX overexpression is associated with poor cancer outcomes. Here, we find that LOX regulates the epidermal growth factor receptor (EGFR) to drive tumour progression. We show that LOX regulates EGFR by...
Autores principales: | Tang, HaoRan, Leung, Leo, Saturno, Grazia, Viros, Amaya, Smith, Duncan, Di Leva, Gianpiero, Morrison, Eamonn, Niculescu-Duvaz, Dan, Lopes, Filipa, Johnson, Louise, Dhomen, Nathalie, Springer, Caroline, Marais, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399287/ https://www.ncbi.nlm.nih.gov/pubmed/28416796 http://dx.doi.org/10.1038/ncomms14909 |
Ejemplares similares
-
Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface
por: Tang, HaoRan, et al.
Publicado: (2019) -
Anti-metastatic
Inhibitors of Lysyl Oxidase (LOX):
Design and Structure–Activity Relationships
por: Leung, Leo, et al.
Publicado: (2019) -
2-Aminomethylene-5-sulfonylthiazole
Inhibitors
of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying
Tumor Growth
por: Smithen, Deborah A., et al.
Publicado: (2019) -
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers
por: Saturno, G., et al.
Publicado: (2021) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
por: Vallet, Sylvain D., et al.
Publicado: (2020)